LACTIC ACID BACTERIUM-CONTAINING PREPARATION
An object of the present invention is to provide a useful composition that contains a highly safe lactic acid bacterium or a component derived from this lactic acid bacterium. The present invention relates to a composition comprising at least one lactic acid bacterium selected from the group consisting of Lactobacillus delbrueckii subsp. lactis strain KR-037 (NITE BP-395), Lactobacillus delbrueckii subsp. lactis strain KLAB-4 (NITE BP-394), and variants thereof, or comprising a component derived from the lactic acid bacterium. The composition of the present invention is useful as a preparation that has an excellent antiallergic function and also has at least one other function selected from an anti-autoimmune disease function, a diabetes-improving function, a neutral fat-lowering function, and so forth.
1 . A composition comprising at least one lactic acid bacterium selected from the group consisting of Lactobacillus delbrueckii KLAB-4 (NITE BP-394), Lactobacillus delbrueckii KR-037 (NITE BP-395), and variants thereof, or comprising a component derived from the lactic acid bacterium.
2 . The composition according to claim 1 , wherein the lactic acid bacterium is viable or dead.
3 . The composition according to claim 1 , wherein the component derived from the lactic acid bacterium is a residue from the hot water extraction of the lactic acid bacterium.
4 . The composition according to claim 1 , which is an antiallergic agent.
5 . The composition according to claim 1 , which is an anti-autoimmune disease agent.
6 . The composition according to claim 1 , which is a diabetes-improving agent.
7 . The composition according to claim 1 , which is a neutral fat-lowering agent.
8 . A food containing the composition according to claim 1 .
9 . The food according to claim 8 , which is a functional food or a supplement.
10 . A feed containing the composition according to claim 1 .
11 . A drug or animal drug containing the composition according to claim 1 .
12 . A method of treating an allergic disease, comprising:
administering to a subject a composition containing at least one lactic acid bacterium selected from the group consisting of Lactobacillus delbrueckii KLAB-4 (NITE BP-394), Lactobacillus delbrueckii KR-037 (NITE BP-395), and variants thereof, or containing a component derived from the lactic acid bacterium.
13 . The method according to claim 12 , wherein the allergic disease is hay fever or atopic dermatitis.
14 . Lactobacillus delbrueckii KLAB-4 (NITE BP-394).
15 . Lactobacillus delbrueckii KR-037 (NITE BP-395).
16 . The composition according to claim 2 , which is an antiallergic agent.
17 . The composition according to claim 3 , which is an antiallergic agent.
18 . The composition according to claim 2 , which is an anti-autoimmune disease agent.
19 . The composition according to claim 3 , which is an anti-autoimmune disease agent
20 . The composition according to claim 2 , which is a diabetes-improving agent.